BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7904537)

  • 1. 5-Fluorouracil increases susceptibility of renal cell cancer cell lines to lymphokine-activated killer cells: evidence for alteration not at the level of recognition but at a post-binding stage of the lytic cycle.
    Tomita Y; Imai T; Katagiri A; Kimura M; Saitoh K; Sato S
    Cancer Lett; 1993 Nov; 75(1):27-34. PubMed ID: 7904537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-induced protection of renal cell cancer cell line from lysis by natural killer cells and increase of susceptibility by treatment with 5-fluorouracil.
    Imai T; Katagiri A; Saito K; Tomita Y
    Cancer Lett; 1995 Aug; 94(2):191-7. PubMed ID: 7634247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
    Tomita Y; Watanabe H; Kobayashi H; Nishiyama T; Tsuji S; Fujiwara M; Sato S
    Cancer Immunol Immunother; 1992; 35(6):381-7. PubMed ID: 1356627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
    Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
    Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
    Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
    Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon-induced protection of renal cell cancer cell lines to lymphokine-activated killer (LAK) cells and effect of acid treatment on their susceptibility. Its relevance to expression of major histocompatibility complex class I antigens on tumor cells].
    Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):762-8. PubMed ID: 1908533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
    Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
    Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.
    Oblakowski P; Bello-Fernandez C; Reittie JE; Heslop HE; Galatowicz G; Veys P; Wilkes S; Prentice HG; Hazlehurst G; Hoffbrand AV
    Blood; 1991 May; 77(9):1996-2001. PubMed ID: 1708296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
    Gwin JL; Gercel-Taylor C; Taylor DD; Eisenberg B
    J Surg Res; 1996 Jan; 60(1):129-36. PubMed ID: 8592403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
    Falk CS; Noessner E; Weiss EH; Schendel DJ
    Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different susceptibilities of lymphokine-activated killer cells (LAK cells) among primary and metastatic renal cell carcinoma derived from the same patient.
    Hattori T; Satoh M; Nishimura T; Kawamura N; Akimoto M
    Br J Urol; 1995 Apr; 75(4):448-51. PubMed ID: 7788254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
    Chong AS; Boussy IA; Graf LH; Scuderi P
    Cell Immunol; 1992 Oct; 144(1):69-79. PubMed ID: 1356634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
    Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
    Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecules on murine lymphokine-activated killer cells responsible for target cell killing: a role of CD2.
    Kato K; Tanabe T; Yagita H; Agatsuma T; Hojo H; Hashimoto Y
    Jpn J Cancer Res; 1991 Oct; 82(10):1139-44. PubMed ID: 1683349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
    Correale P; Procopio A; Celio L; Caraglia M; Genua G; Coppola V; Pepe S; Normanno N; Vecchio I; Palmieri G
    Cancer Immunol Immunother; 1992; 34(4):272-8. PubMed ID: 1371427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
    Gross N; Favre S; Beck D; Meyer M
    Int J Cancer; 1992 Aug; 52(1):85-91. PubMed ID: 1354203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
    Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
    Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.